We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights Microsoft, Alibaba Group, Medtronic, Illinois Tool Works and Fiserv
Read MoreHide Full Article
For Immediate Release
Chicago, IL – March 15, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Microsoft Corp. (MSFT - Free Report) , Alibaba Group Holding Ltd. (BABA - Free Report) , Medtronic plc (MDT - Free Report) , Illinois Tool Works Inc. (ITW - Free Report) and Fiserv, Inc. .
Here are highlights from Tuesday’s Analyst Blog:
Top Stock Reports for Microsoft, Alibaba and Medtronic
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 15 major stocks, including Microsoft Corp., Alibaba Group Holding Ltd. and Medtronic plc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Shares of Microsoft have gained +4.9% over the past six months against the Zacks Computer - Software industry's gain of +6.3%. The company is benefitting from consistent execution across renewal sales motions, including strong recapture rates and growth in Azure cloud platform amid accelerated global digital transformation.
Slow yet steady performance of Office 365 and Dynamics is aiding user growth thereby driving the top-line. Strength in Marketing Solutions and steady performance in Talent Solutions is driving LinkedIn revenues boosted by recovery in advertising and job market. We expect fiscal 2023 revenues to grow by 4.7% over fiscal 2022.
However, a slowdown in its cloud business and declining videogame sales were headwinds. Decrease in Xbox content and services and Xbox hardware hurt gaming sales due to a decline in first-party content. Increasing spend on Azure enhancements amid stiff competition in the cloud space from Amazon is likely to dent margins.
Alibaba's shares have outperformed the Zacks Internet - Commerce industry over the past year (+7.6% vs. -25.5%). The company's top-line was driven by growing momentum across Alibaba's international commerce retail business. The Zacks analyst expects the business to be up 9.1% in fiscal 2023 on a year-over-year basis.
Additionally, solid momentum across financial services, education and automobile industries is driving the company's cloud business. This apart, strength across the local consumer services and Cainiao logistics services, Alibaba Health and Freshippo is contributing well.
However, uncertainties associated with coronavirus pandemic remain major concerns, especially for Alibaba's domestic businesses. Also, rising expenses associated with new initiatives are overhangs.
Shares of Medtronic have declined -24.9% over the past year against the Zacks Medical - Products industry's decline of -39.3%. The company's innovations and market expansion efforts are helping it offset the impact of the high inflation and supply disruptions. The Zacks analyst expects its 2023 adjusted earnings will dip 4.8% from the year-ago period on 2% revenue growth at CER.
However, Medtronic is strategically expanding its global presence to address the unmet demand for advanced medical technologies. We expect Medtronic to register an international sales CAGR of 2.5% through 2025. Within cardiovascular, Medtronic is gaining market share, banking on product launches. Within MedSurg, Medtronic is scaling production of Hugo RAS.
Medtronic's strong liquidity position should allow it to meet its near-term debt obligations. All these factors support our bullish stance on the stock.
Other noteworthy reports we are featuring today include Illinois Tool Works Inc. and Fiserv, Inc..
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights Microsoft, Alibaba Group, Medtronic, Illinois Tool Works and Fiserv
For Immediate Release
Chicago, IL – March 15, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Microsoft Corp. (MSFT - Free Report) , Alibaba Group Holding Ltd. (BABA - Free Report) , Medtronic plc (MDT - Free Report) , Illinois Tool Works Inc. (ITW - Free Report) and Fiserv, Inc. .
Here are highlights from Tuesday’s Analyst Blog:
Top Stock Reports for Microsoft, Alibaba and Medtronic
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 15 major stocks, including Microsoft Corp., Alibaba Group Holding Ltd. and Medtronic plc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today's research reports here >>>
Shares of Microsoft have gained +4.9% over the past six months against the Zacks Computer - Software industry's gain of +6.3%. The company is benefitting from consistent execution across renewal sales motions, including strong recapture rates and growth in Azure cloud platform amid accelerated global digital transformation.
Slow yet steady performance of Office 365 and Dynamics is aiding user growth thereby driving the top-line. Strength in Marketing Solutions and steady performance in Talent Solutions is driving LinkedIn revenues boosted by recovery in advertising and job market. We expect fiscal 2023 revenues to grow by 4.7% over fiscal 2022.
However, a slowdown in its cloud business and declining videogame sales were headwinds. Decrease in Xbox content and services and Xbox hardware hurt gaming sales due to a decline in first-party content. Increasing spend on Azure enhancements amid stiff competition in the cloud space from Amazon is likely to dent margins.
(You can read the full research report on Microsoft here >>>)
Alibaba's shares have outperformed the Zacks Internet - Commerce industry over the past year (+7.6% vs. -25.5%). The company's top-line was driven by growing momentum across Alibaba's international commerce retail business. The Zacks analyst expects the business to be up 9.1% in fiscal 2023 on a year-over-year basis.
Additionally, solid momentum across financial services, education and automobile industries is driving the company's cloud business. This apart, strength across the local consumer services and Cainiao logistics services, Alibaba Health and Freshippo is contributing well.
However, uncertainties associated with coronavirus pandemic remain major concerns, especially for Alibaba's domestic businesses. Also, rising expenses associated with new initiatives are overhangs.
(You can read the full research report on Alibaba here >>>)
Shares of Medtronic have declined -24.9% over the past year against the Zacks Medical - Products industry's decline of -39.3%. The company's innovations and market expansion efforts are helping it offset the impact of the high inflation and supply disruptions. The Zacks analyst expects its 2023 adjusted earnings will dip 4.8% from the year-ago period on 2% revenue growth at CER.
However, Medtronic is strategically expanding its global presence to address the unmet demand for advanced medical technologies. We expect Medtronic to register an international sales CAGR of 2.5% through 2025. Within cardiovascular, Medtronic is gaining market share, banking on product launches. Within MedSurg, Medtronic is scaling production of Hugo RAS.
Medtronic's strong liquidity position should allow it to meet its near-term debt obligations. All these factors support our bullish stance on the stock.
(You can read the full research report on Medtronic here >>>)
Other noteworthy reports we are featuring today include Illinois Tool Works Inc. and Fiserv, Inc..
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +6.2 average gain per year. Amazingly, they soared with average gains of +46.4%, +49.5% and +55.2% per year. Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.